Page results
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease. It outlines the importance of having your heart checked as part of your care.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
UCLH will play a vital role in a new respiratory virus study.
File results
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks